Genetic Markers and Proliferative Diabetic Retinopathy

计划入组 302 人 · 首次发布于 2016 年 8 月 25 日

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

计划入组 675 人 · 首次发布于 2019 年 9 月 10 日

C677T Methylenetetrahydrofolate Reductase Mutation

计划入组 363 人 · 首次发布于 2023 年 5 月 18 日

aldose reductase inhibitors (Kowa)

PA-2612

ALR2 Inhibitors (Beijing Institute of Technology (BIT))

Alios BioPharma, Inc.

United States

ALTOS BIOLOGICS, INC.

South Korea

Allos Therapeutics, Inc.

United States

Govorestat: FDA Approval Status and Its Role in Treating Galactosemia

Applied Therapeutics Awaits FDA Decision on Govorestat for Galactosemia

Applied Therapeutics to Present Extended INSPIRE Trial Data for Govorestat in SORD Deficiency at PNS Annual Meeting